FREQ insider filings
Frequency Therapeutics, Inc. — 49 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-08-22. Screen FREQ transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for FREQ between 2026-07-10 and 2026-10-08. The table below lists the most recent filings on record.
Recent insider filings — Frequency Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-08-22 | 4 | Mitrano Richard J. — VP Finance & Operations | Sale (S): 227 @ $0.63 · Sale (S): 237 @ $0.53 | EDGAR |
| 2023-08-22 | 4 | Lucchino David L. — President and CEO, Director | Sale (S): 2,865 @ $0.60 · Sale (S): 3,057 @ $0.50 | EDGAR |
| 2023-08-18 | 4 | Mitrano Richard J. — VP Finance & Operations | Sale (S): 234 @ $0.67 · Sale (S): 230 @ $0.62 | EDGAR |
| 2023-08-18 | 4 | Lucchino David L. — President and CEO, Director | Sale (S): 2,895 @ $0.65 · Sale (S): 2,733 @ $0.63 | EDGAR |
| 2023-08-16 | 4 | Mitrano Richard J. — VP Finance & Operations | Sale (S): 238 @ $0.64 · Sale (S): 228 @ $0.65 | EDGAR |
| 2023-08-16 | 4 | Lucchino David L. — President and CEO, Director | Sale (S): 2,881 @ $0.63 · Sale (S): 2,629 @ $0.67 | EDGAR |
| 2023-08-14 | 4 | Lucchino David L. — President and CEO, Director | Sale (S): 2,790 @ $0.68 · Sale (S): 2,733 @ $0.67 | EDGAR |
| 2023-08-14 | 4 | Mitrano Richard J. — VP Finance & Operations | Sale (S): 247 @ $0.64 · Sale (S): 240 @ $0.64 | EDGAR |
| 2023-08-10 | 4 | Lucchino David L. — President and CEO, Director | Sale (S): 2,810 @ $0.69 · Sale (S): 2,798 @ $0.67 | EDGAR |
| 2023-08-10 | 4 | Mitrano Richard J. — VP Finance & Operations | Sale (S): 241 @ $0.67 · Sale (S): 238 @ $0.66 | EDGAR |
| 2023-08-09 | 4 | Lucchino David L. — President and CEO, Director | Sale (S): 2,550 @ $0.69 · Sale (S): 2,857 @ $0.68 | EDGAR |
| 2023-08-09 | 4 | Mitrano Richard J. — VP Finance & Operations | Sale (S): 220 @ $0.67 · Sale (S): 235 @ $0.69 | EDGAR |
| 2023-08-04 | 4 | Lucchino David L. — President and CEO, Director | Sale (S): 2,587 @ $0.52 · Sale (S): 2,679 @ $0.59 | EDGAR |
| 2023-08-04 | 4 | Mitrano Richard J. — VP Finance & Operations | Sale (S): 231 @ $0.49 · Sale (S): 232 @ $0.56 | EDGAR |
| 2023-08-02 | 4 | Lucchino David L. — President and CEO, Director | Sale (S): 2,676 @ $0.50 · Sale (S): 2,799 @ $0.49 | EDGAR |
| 2023-08-02 | 4 | Mitrano Richard J. — VP Finance & Operations | Sale (S): 222 @ $0.50 · Sale (S): 238 @ $0.48 | EDGAR |
| 2023-07-31 | 4 | Mitrano Richard J. — VP Finance & Operations | Sale (S): 227 @ $0.53 · Sale (S): 223 @ $0.47 | EDGAR |
| 2023-07-31 | 4 | Lucchino David L. — President and CEO, Director | Sale (S): 2,791 @ $0.51 · Sale (S): 2,647 @ $0.47 | EDGAR |
| 2023-07-31 | 4 | Loose Christopher R. — Chief Scientific Officer | Sale (S): 1,373 @ $0.53 · Sale (S): 1,344 @ $0.46 | EDGAR |
| 2023-07-27 | 4 | Mitrano Richard J. — VP Finance & Operations | Sale (S): 234 @ $0.50 · Sale (S): 222 @ $0.53 | EDGAR |
| 2023-07-27 | 4 | Loose Christopher R. — Chief Scientific Officer | Sale (S): 1,390 @ $0.50 · Sale (S): 1,329 @ $0.51 | EDGAR |
| 2023-07-27 | 4 | Lucchino David L. — President and CEO, Director | Sale (S): 2,803 @ $0.50 · Sale (S): 2,609 @ $0.52 | EDGAR |
| 2023-07-25 | 4 | Loose Christopher R. — Chief Scientific Officer | Sale (S): 1,333 @ $0.61 · Sale (S): 1,438 @ $0.54 | EDGAR |
| 2023-07-25 | 4 | Lucchino David L. — President and CEO, Director | Sale (S): 2,663 @ $0.61 · Sale (S): 2,887 @ $0.54 | EDGAR |
| 2023-07-25 | 4 | Mitrano Richard J. — VP Finance & Operations | Sale (S): 223 @ $0.61 · Sale (S): 234 @ $0.56 | EDGAR |
| 2023-07-21 | 4 | Loose Christopher R. — Chief Scientific Officer | Sale (S): 1,335 @ $0.65 · Sale (S): 1,361 @ $0.64 | EDGAR |
| 2023-07-21 | 4 | Lucchino David L. — President and CEO, Director | Sale (S): 2,646 @ $0.65 · Sale (S): 2,710 @ $0.64 | EDGAR |
| 2023-07-21 | 4 | Mitrano Richard J. — VP Finance & Operations | Sale (S): 228 @ $0.63 · Sale (S): 229 @ $0.64 | EDGAR |
| 2023-07-19 | 4 | Mitrano Richard J. — VP Finance & Operations | Sale (S): 244 @ $0.65 · Sale (S): 249 @ $0.56 | EDGAR |
| 2023-07-19 | 4 | Lucchino David L. — President and CEO, Director | Sale (S): 2,775 @ $0.68 · Sale (S): 2,968 @ $0.56 | EDGAR |
| 2023-07-19 | 4 | Loose Christopher R. — Chief Scientific Officer | Sale (S): 1,415 @ $0.67 · Sale (S): 1,484 @ $0.56 | EDGAR |
| 2023-07-17 | 4 | Loose Christopher R. — Chief Scientific Officer | Sale (S): 1,329 @ $0.39 · Sale (S): 906 @ $0.59 | EDGAR |
| 2023-07-17 | 4 | Lucchino David L. — President and CEO, Director | Sale (S): 2,646 @ $0.39 · Sale (S): 1,815 @ $0.59 | EDGAR |
| 2023-07-17 | 4 | Mitrano Richard J. — VP Finance & Operations | Sale (S): 227 @ $0.39 · Sale (S): 148 @ $0.60 | EDGAR |
| 2023-07-13 | 4 | Loose Christopher R. — Chief Scientific Officer | Sale (S): 1,363 @ $0.37 · Sale (S): 1,335 @ $0.39 | EDGAR |
| 2023-07-13 | 4 | Lucchino David L. — President and CEO, Director | Sale (S): 2,731 @ $0.37 · Sale (S): 2,649 @ $0.39 | EDGAR |
| 2023-07-13 | 4 | Mitrano Richard J. — VP Finance & Operations | Sale (S): 228 @ $0.37 · Sale (S): 220 @ $0.40 | EDGAR |
| 2023-07-12 | 4/A | Mitrano Richard J. — VP Finance & Operations | Sale (S): 220 @ $0.36 · Sale (S): 220 @ $0.37 | EDGAR |
| 2023-07-12 | 4/A | Lucchino David L. — President and CEO, Director | Sale (S): 2,634 @ $0.35 · Sale (S): 2,591 @ $0.38 | EDGAR |
| 2023-07-12 | 4/A | Loose Christopher R. — Chief Scientific Officer | Sale (S): 1,306 @ $0.36 · Sale (S): 1,304 @ $0.37 | EDGAR |
| 2023-07-12 | 4/A | Mitrano Richard J. — VP Finance & Operations | Option exercise (M): 25,000 · Sale (S): 224 @ $0.35 · Option exercise (M): 25,000 (derivative) | EDGAR |
| 2023-07-12 | 4/A | Lucchino David L. — President and CEO, Director | Gift (G): 13,345 @ $0 · Gift (G): 33,345 @ $0 · Option exercise (M): 300,000 · Sale (S): 2,773 @ $0.34 · Option exercise (M): 300,000 (derivative) | EDGAR |
| 2023-07-12 | 4/A | Loose Christopher R. — Chief Scientific Officer | Option exercise (M): 150,000 · Sale (S): 1,384 @ $0.34 · Option exercise (M): 150,000 (derivative) | EDGAR |
| 2023-07-11 | 4 | Loose Christopher R. — Chief Scientific Officer | Sale (S): 1,306 @ $0.36 · Option exercise (M): 4,546 · Sale (S): 1,304 @ $0.37 · Option exercise (M): 4,546 · Option exercise (M): 4,546 (derivative) · Option exercise (M): 4,546 (derivative) | EDGAR |
| 2023-07-11 | 4 | Mitrano Richard J. — VP Finance & Operations | Sale (S): 220 @ $0.36 · Option exercise (M): 758 · Sale (S): 220 @ $0.37 · Option exercise (M): 758 · Option exercise (M): 758 (derivative) · Option exercise (M): 758 (derivative) | EDGAR |
| 2023-07-11 | 4 | Lucchino David L. — President and CEO, Director | Sale (S): 2,634 @ $0.35 · Option exercise (M): 9,091 · Sale (S): 2,591 @ $0.38 · Option exercise (M): 9,091 · Option exercise (M): 9,091 (derivative) · Option exercise (M): 9,091 (derivative) | EDGAR |
| 2023-07-07 | 4 | Mitrano Richard J. — VP Finance & Operations | Option exercise (M): 758 · Sale (S): 224 @ $0.35 · Option exercise (M): 758 · Option exercise (M): 758 (derivative) · Option exercise (M): 758 (derivative) | EDGAR |
| 2023-07-07 | 4 | Lucchino David L. — President and CEO, Director | Option exercise (M): 9,091 · Sale (S): 2,773 @ $0.34 · Option exercise (M): 9,091 · Option exercise (M): 9,091 (derivative) · Option exercise (M): 9,091 (derivative) | EDGAR |
| 2023-07-07 | 4 | Loose Christopher R. — Chief Scientific Officer | Option exercise (M): 4,546 · Option exercise (M): 4,546 · Sale (S): 1,384 @ $0.34 · Option exercise (M): 4,546 (derivative) · Option exercise (M): 4,546 (derivative) | EDGAR |
Recent 8-K events — Frequency Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-10-05 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-19 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-08-06 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.02 — Results of Operations and Financial Condition 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-11 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-19 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-09 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.02 — Results of Operations and Financial Condition 3.02 — Unregistered Sales of Equity Securities 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-27 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-15 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=FREQ returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →